INVO Fertility (NASDAQ:IVF) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of INVO Fertility (NASDAQ:IVF) from a sell rating to a hold rating in a report published on Saturday.

Separately, Maxim Group set a $4.00 price target on shares of INVO Fertility in a report on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $4.00.

INVO Fertility Stock Down 2.2%

IVF stock opened at $0.85 on Friday. INVO Fertility has a 52 week low of $0.71 and a 52 week high of $103.68. The firm has a market capitalization of $5.91 million, a P/E ratio of 0.00 and a beta of 2.66. The company has a fifty day simple moving average of $1.08 and a two-hundred day simple moving average of $3.57.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in INVO Fertility stock. Citadel Advisors LLC acquired a new stake in shares of INVO Fertility, Inc (NASDAQ:IVF) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned about 1.19% of INVO Fertility as of its most recent SEC filing. Institutional investors own 12.02% of the company’s stock.

INVO Fertility Company Profile

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.